Keyphrases
Direct-acting Antivirals
100%
Hepatitis C Virus
100%
Epigenetic Signature
100%
Post-curing
100%
Epigenetic Modification
83%
Hepatocellular Carcinoma
50%
Sustained Virological Response
50%
Epigenetics
33%
Direct-acting Antiviral Treatment
33%
Hepatitis C Virus Infection
33%
Novel Mechanism
16%
Signaling Pathway
16%
Europe
16%
Epidemiological Study
16%
Scar
16%
Risk Factors
16%
Histone Modification
16%
Poor Prognosis
16%
Gene Signature
16%
Chromatin Immunoprecipitation (ChIP)
16%
Chromatin
16%
Hepatocellular Carcinoma Progression
16%
Tumor Development
16%
Biopsy Specimen
16%
Pathogenic Mechanism
16%
Viral Proteins
16%
Interferon-α (IFN-α)
16%
Virus-specific
16%
Liver Biopsy
16%
Next-generation Sequencing
16%
Hepatitis C Virus RNA
16%
Conventional Chemotherapy
16%
Global Prevalence
16%
Histone Post-translational Modifications
16%
Epigenetic Marks
16%
Virus Life Cycle
16%
Virus Removal
16%
EGFR Inhibitors
16%
Erlotinib
16%
Host Gene Expression
16%
Virus Infection Model
16%
Hepatitis C Virus Eradication
16%
Chronic Hepatitis Infection
16%
Medicine and Dentistry
Infection
100%
Hepatitis C Virus
100%
Antiviral Drug
100%
Hepatocellular Carcinoma
50%
In Vitro
25%
Antiviral Therapy
25%
Hepatitis C
25%
Viral Clearance
25%
Prevalence
12%
Gene Expression
12%
Neoplasm
12%
Carcinogenesis
12%
Interferon
12%
Life Cycle
12%
Virus RNA
12%
Scar Formation
12%
Liver Biopsy
12%
Next Generation Sequencing
12%
Histone
12%
Biopsy Sample
12%
Chromatin Immunoprecipitation
12%
Viral Protein
12%
EGFR Inhibitors
12%
Erlotinib
12%
Chronic Hepatitis
12%
Cell Signaling Pathway
12%
Histone Modification
12%
Post-Translational Modification
12%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Hepatitis C Virus
100%
Antiviral Drug
100%
Liver Cell Carcinoma
50%
Histone
25%
Hepatitis C
25%
Viral Clearance
25%
Prevalence
12%
Chemotherapy
12%
Neoplasm
12%
Carcinogenesis
12%
Scar Formation
12%
Epidermal Growth Factor Receptor
12%
Interferon
12%
Viral Protein
12%
Virus RNA
12%
Chronic Hepatitis
12%
Chromatin Immunoprecipitation
12%
Erlotinib
12%
Immunology and Microbiology
Hepatitis C Virus
100%
Hepatitis C
25%
Viral Clearance
25%
Gene Expression
12%
Prevalence
12%
RNA Virus
12%
Life Cycle
12%
Viral Protein
12%
Scar Formation
12%
Next Generation Sequencing
12%
interferon
12%
Chromatin Immunoprecipitation
12%
Histone Modification
12%
Histone
12%
Post-Translational Modification
12%